Chang-Sheng Ma from the Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, Beijing, China considers the use of direct oral anticoagulants for prevention of stroke and systemic embolic events in East Asian patients with nonvalvular atrial fibrillation.
All news from Anaesthesiology
Researchers explained that the ancient practice of tai chi may beat strength training and aerobics for preventing falls among seniors, according to the new trial
Researchers are beginning recruitment in a trial to see if changing pregnant women's hygiene habits could reduce the risks of a major cause of childhood disabilities
High adherence to the Mediterranean diet score is tied to lower risk of rheumatoid arthritis (RA) in some populations, according to a study published online Aug. 9 in Arthritis Research & Therapy
Utilizing new mobile application technology, researchers at The University of New Mexico found that medical cannabis provides immediate symptom relief across dozens of health symptoms with relatively minimal negative side effects
In what is believed to be the largest study investigating genetic and clinical determinants of osteoporotic fracture risk, only a genetic predisposition to low bone mineral density (BMD) had a potential causal role to play
Among Medicare beneficiaries with self-reported vision impairment, Hispanic individuals and those from other races/ethnicities are less likely to report using low-vision devices than white individuals in a model adjusted for ocular diagnoses, according to a study published online Sept. 6 in JAMA Ophthalmology.
In the study, they evaluated the value of I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (I-FP-CIT) dopamine transporter single photon emission computed tomography (DAT-SPECT) to change management strategies of patients suspected of parkinsonism
The benefits of the dopamine agonist apomorphine in Parkinson's disease have finally been confirmed in a randomized controlled trial, although the drug has been used in the condition for many years
In an editorial published online September 1 in the Annals of Oncology, Giuseppe Procopio, MD, Department of Medical Oncology, Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Italy, and colleagues point out that in the pivotal trial of the adjuvant use of sunitinib (Sutent, Pfizer Inc), the drug did not improve overall survival, although there was an increase in disease-free survival
Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur